Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cognetivity Neurosciences (CGNSF)
OTHER OTC:CGNSF
Holding CGNSF?
Track your performance easily
CGNSF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume100.00
Average Volume (3M)11.40K
Market Cap
$618.37K
Enterprise ValueN/A
Total Cash (Recent Filing)$32.23K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding89,588,610
10 Day Avg. Volume2,290
30 Day Avg. Volume11,402
Standard Deviation0.38
R-Squared0.00004
Alpha0.00614
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)107.41
Price to Cash Flow (P/CF)N/A
P/FCF Ratio2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cognetivity Neurosciences News
Options Prices
Currently, No data available
---
Ownership Overview
CGNSF FAQ
What was Cognetivity Neurosciences’s price range in the past 12 months?
Cognetivity Neurosciences lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Cognetivity Neurosciences’s market cap?
Cognetivity Neurosciences’s market cap is $618.37K.
When is Cognetivity Neurosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cognetivity Neurosciences’s earnings last quarter?
Currently, no data Available
Is Cognetivity Neurosciences overvalued?
According to Wall Street analysts Cognetivity Neurosciences’s price is currently Overvalued.
Does Cognetivity Neurosciences pay dividends?
Cognetivity Neurosciences does not currently pay dividends.
What is Cognetivity Neurosciences’s EPS estimate?
Cognetivity Neurosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cognetivity Neurosciences have?
Cognetivity Neurosciences has 89,588,610 shares outstanding.
What happened to Cognetivity Neurosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cognetivity Neurosciences?
Currently, no hedge funds are holding shares in CGNSF
---
Company Description
Cognetivity Neurosciences
Cognetivity Neurosciences Ltd is developing a platform technology comprising of a visual stimulus based diagnostic test and artificial intelligence tools to support the early detection and monitoring of cognitive impairment in neurodegenerative diseases, with initial emphasis on dementia in Alzheimer's disease and mild cognitive impairment, a difficult-to-diagnose, "pre-dementia" condition.
---
BlackBerry
―
Knight Therapeutics
―
Sernova
―
Neo Performance Materials Inc
―
HLS Therapeutics Inc
―
---